Related Experiment Videos
Mycobacterium leprae and leprosy: a compendium.
S Sasaki1, F Takeshita, K Okuda
1Department of Bioregulation, Leprosy Research Center, National Institute of Infectious Diseases, Higashimurayama, Tokyo, Japan. ssasaki@nih.go.jp
Microbiology and Immunology
|January 17, 2002
Summary
Leprosy, caused by Mycobacterium leprae, is a chronic infection affecting peripheral nerves. While multidrug therapy (MDT) controls the disease, host immune response and bacterial factors influence its clinical presentation.
Area of Science:
- Microbiology
- Immunology
- Neurology
Background:
- Leprosy is a chronic infectious disease caused by Mycobacterium leprae, a bacterium with unique characteristics like a long generation time and inability to grow in artificial media.
- The bacterium's genome contains numerous pseudogenes, potentially explaining its limited metabolic activity.
- Clinical manifestations of leprosy are heavily influenced by the host's immune response, with Th1-type immunity being protective and Th2-type immunity associated with disease progression.
Purpose of the Study:
- To provide a comprehensive overview of leprosy, encompassing its causative agent, pathogenesis, host-pathogen interactions, and current treatment strategies.
- To discuss the neurological aspects of leprosy, specifically the interaction between Mycobacterium leprae and Schwann cells.
- To address the historical stigma associated with leprosy and recent developments in Japan.
Main Methods:
- Review of existing literature on Mycobacterium leprae, leprosy pathogenesis, and immunology.
- Analysis of genomic data of M. leprae to understand its metabolic limitations.
- Examination of molecular interactions between M. leprae components and host cells (Schwann cells).
- Discussion of World Health Organization (WHO) recommended multidrug therapy (MDT) protocols.
Main Results:
- Mycobacterium leprae possesses unique genomic features, including numerous pseudogenes, contributing to its slow metabolism.
- Host immune response plays a critical role in leprosy, with Th1 immunity clearing the bacteria and Th2 immunity exacerbating the disease.
- M. leprae targets peripheral nerves by binding to Schwann cell surface receptors (alpha/beta dystroglycan complexes) via M. leprae/laminin-alpha2 complexes, leading to neuropathy.
- Multidrug therapy (MDT) is effective in controlling leprosy and supporting global elimination efforts.
Conclusions:
- Leprosy pathogenesis is complex, involving bacterial factors, host immune responses, and specific nerve tropism.
- Understanding the molecular interactions between M. leprae and host cells is crucial for developing targeted therapies.
- Effective control and elimination of leprosy rely on continued implementation of multidrug therapy (MDT) and addressing the associated social stigma.